Switch to:
ISIS Pharmaceuticals Inc (NAS:ISIS)
EV/EBITDA
-319.22 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, ISIS Pharmaceuticals Inc's enterprise value is $7,271.0 Mil. ISIS Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Dec. 2014 was $-22.8 Mil. Therefore, ISIS Pharmaceuticals Inc's EV/EBITDA ratio for today is -319.22.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, ISIS Pharmaceuticals Inc's stock price is $63.37. ISIS Pharmaceuticals Inc's earnings per share for the trailing twelve months (TTM) ended in Dec. 2014 was $-0.34. Therefore, ISIS Pharmaceuticals Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

ISIS Pharmaceuticals Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=7270.955/-22.777
=-319.22

ISIS Pharmaceuticals Inc's current Enterprise Value is $7,271.0 Mil.
ISIS Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Dec. 2014 was -26.318 (Mar. 2014 ) + -3.909 (Jun. 2014 ) + -17.861 (Sep. 2014 ) + 25.311 (Dec. 2014 ) = $-22.8 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

ISIS Pharmaceuticals Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=63.37/-0.337
=

ISIS Pharmaceuticals Inc's share price for today is $63.37.
ISIS Pharmaceuticals Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Dec. 2014 was -0.27 (Mar. 2014 ) + -0.1 (Jun. 2014 ) + -0.23 (Sep. 2014 ) + 0.263 (Dec. 2014 ) = $-0.34.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

ISIS Pharmaceuticals Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda -7.55-12.58-41.17-405.07-35.36-14.35-6.69-14.37-112.66-308.33

ISIS Pharmaceuticals Inc Quarterly Data

Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14
ev2ebitda -21.03-14.37-53.45-73.13-144.22-112.66-67.49-53.41-65.25-308.33
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK